<code id='D42AB75FD2'></code><style id='D42AB75FD2'></style>
    • <acronym id='D42AB75FD2'></acronym>
      <center id='D42AB75FD2'><center id='D42AB75FD2'><tfoot id='D42AB75FD2'></tfoot></center><abbr id='D42AB75FD2'><dir id='D42AB75FD2'><tfoot id='D42AB75FD2'></tfoot><noframes id='D42AB75FD2'>

    • <optgroup id='D42AB75FD2'><strike id='D42AB75FD2'><sup id='D42AB75FD2'></sup></strike><code id='D42AB75FD2'></code></optgroup>
        1. <b id='D42AB75FD2'><label id='D42AB75FD2'><select id='D42AB75FD2'><dt id='D42AB75FD2'><span id='D42AB75FD2'></span></dt></select></label></b><u id='D42AB75FD2'></u>
          <i id='D42AB75FD2'><strike id='D42AB75FD2'><tt id='D42AB75FD2'><pre id='D42AB75FD2'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:852
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Doudna institute plans to 'cure hundreds of diseases' with CRISPR
          Doudna institute plans to 'cure hundreds of diseases' with CRISPR

          ChristineKao/STATResearchersattendinggenetherapymeetingsoverthepastcoupleyearswereliabletobumpintoas

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Readout LOUD podcast: live from JPM 2024

          Isbiotechbackfromitsdownturn?CanNvidiasolvebiology?Andisitwisetodoadealonapartybus?Wecoverallthatand